Nuvalent, Inc.

NUVL · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $8.0B · 228 employees
89
SEC Filings
$123.96
Close 2026-07-14
228
Employees

Business Summary

Nuvalent, Inc. is a clinical-stage biopharmaceutical company focused on developing precisely targeted small molecule therapies for cancer patients. Leveraging chemistry and structure-based drug design, the company targets clinically proven kinase targets. Its two lead product candidates are zidesamtinib (NVL-520) for ROS1-positive NSCLC and neladalkib (NVL-655) for ALK-positive NSCLC, both designed to overcome resistance, selectivity limitations, and brain metastases challenges of existing therapies.

Latest Stock Quote

NUVL 2026-07-14 $123.96 O:$123.97 H:$123.99 L:$123.95 Vol:3.1M VWAP:$123.9608
origin leaf: null

Next Earnings

Q2 FY2026 — expected 2026-09-16

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-262025-12-310001193125-26-073317EDGAR113K words
2025-02-272024-12-310000950170-25-028328EDGAR111K words
2024-02-272023-12-310000950170-24-020607EDGAR105K words
2023-03-162022-12-310000950170-23-008284EDGAR—
2022-03-292021-12-310001193125-22-087401EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-10-302025-09-300001193125-25-257357EDGAR75K words
2025-08-072025-06-300000950170-25-104532EDGAR74K words
2025-05-082025-03-310000950170-25-066401EDGAR70K words
2024-11-122024-09-300000950170-24-124518EDGAR71K words
2024-08-082024-06-300000950170-24-093285EDGAR68K words
2024-05-092024-03-310000950170-24-056232EDGAR66K words
2023-11-142023-09-300000950170-23-063341EDGAR71K words
2023-08-102023-06-300000950170-23-040937EDGAR69K words
2023-05-112023-03-310000950170-23-020807EDGAR—
2022-11-102022-09-300000950170-22-024138EDGAR—
2022-08-102022-06-300001193125-22-216780EDGAR—
2022-05-122022-03-310001193125-22-148022EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-07-150001193125-26-304126EDGAR7K words
2026-02-260001193125-26-073304EDGAR2K words
2026-01-140001193125-26-012243EDGAR2K words
2025-12-160001193125-25-320150EDGAR1K words
2025-12-100001193125-25-314165EDGAR1K words
2025-11-200001193125-25-288770EDGAR1K words
2025-11-170001193125-25-283893EDGAR3K words
2025-10-300001193125-25-257347EDGAR2K words
2025-09-220001193125-25-209934EDGAR0K words
2025-08-070000950170-25-104531EDGAR2K words

89 total filings indexed. 62 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

ros1-positive-non-small-cell-lung-cancer-(nsclc) alk-positive-non-small-cell-lung-cancer-(nsclc) oncology-/-kinase-inhibitor-therapeutics alk-positive-solid-tumors recist-1.1-(response-evaluation-criteria) blinded-independent-central-review-(bicr) kaplan-meier-survival-analysis prescription-drug-user-fee-act-(pdufa)

Company Identity

CIK0001861560
TickerNUVL
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.nuvalent.com
Listed2021-07-29

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: f2d35f1f626b13ea502de57c6f07bfdf8c0b0ce421dfa507141b5a1044f63750
parent: d6e55a90bd67c1be9486c3cdd16bfb9bae03a46ec9eaf70e921ed1603e26d636
content hash: f4e8127d2a57df164b565b049cd11008acc5f58835092ce9afcd73765b1e61ec
signed: 2026-09-28T12:02:23.190Z
sources: 17 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up NUVL using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on NUVL, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/NUVL (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.